LLGL2 Increases Ca2+ Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma

被引:10
|
作者
Leng, Shusheng [1 ,2 ,3 ]
Xie, Fei [4 ]
Liu, Junyi [5 ]
Shen, Junyi [1 ,2 ]
Quan, Guangqian [1 ,2 ]
Wen, Tianfu [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Chengdu, Peoples R China
[3] Chengdu Univ, Clin Med Coll, Affiliated Hosp, Gen Surg Dept, Chengdu, Peoples R China
[4] First Peoples Hosp Neijiang City, Dept Hepatobiliary Pancreat & Splen Surg, Neijiang, Peoples R China
[5] Chengdu Univ, Clin Med Coll, Affiliated Hosp, Cent Lab, Chengdu, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
LLGL2; Hepatocellular Carcinoma; PI3K; AKT signaling; Calcium influx; Progression; HUMAN HOMOLOG; DROSOPHILA; LGL; HUGL-1; POLARITY; EXPRESSION; MORPHOGENESIS; DIVISION; CLONING; GROWTH;
D O I
10.3389/fonc.2021.683629
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Lethal giant larvae (Lgl), scaffolding proteins, regulate the epithelial cell apicobasal polarity in Drosophila. They play important roles in asymmetric cell division, cell migration, and progenitor cells self-renewal as tumor suppressors. One of Lgl mammalian homologues proteins, LLGL2 overexpression has been reported in ER+ breast cancer and promotes tumor proliferation through regulating leucine uptake. Nonetheless, the role of LLGL2 in hepatocellular carcinoma (HCC) is still unknown. Methods TCGA dataset mining, qRT-PCR, Western blot along with immunohistochemistry assays were employed to explore LLGL2 expression in human HCC samples and cell lines. Moreover, the clinical value of LLGL2 was investigated in 156 HCC patients. Furthermore, the role as well as the molecular mechanism of LLGL2 in the progression of HCC was explored through a series of in vitro and in vivo experiments. Results LLGL2 was up-regulated in HCC tissues, which was related with certain clinicopathological features including tumor number, vascular invasion as well as advanced stage. High expression of LLGL2 predicted poor prognosis after hepatectomy. LLGL2 promoted HCC cells proliferation, migration and invasion through PI3K/ATK signaling by promoting calcium ion influx. Conclusion Our study identified that LLGL2 is a tumor promoter in HCC for the first time, which could potentially be utilized as a new biomarker and a therapeutic target for HCC.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
    Junbin Liao
    Huilin Jin
    Shaoqiang Li
    Lixia Xu
    Zhenwei Peng
    Guangyan Wei
    Jianting Long
    Yu Guo
    Ming Kuang
    Qi Zhou
    Sui Peng
    Journal of Experimental & Clinical Cancer Research, 38
  • [22] Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
    Bang, Jieun
    Jun, Mihyeon
    Lee, Soyun
    Moon, Hyuk
    Ro, Simon Weonsang
    PHARMACEUTICS, 2023, 15 (08)
  • [23] The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
    Tian, Ling-Yu
    Smit, Daniel J.
    Juecker, Manfred
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [24] Puerarin attenuates the daunorubicin-induced apoptosis of H9c2 cells by activating the PI3K/Akt signaling pathway via the inhibition of Ca2+ influx
    Li, Weihua
    Lu, Min
    Zhang, Yanhong
    Xia, Danqin
    Chen, Zebin
    Wang, Linhua
    Yin, Nina
    Wang, Zhigang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 (06) : 1889 - 1894
  • [25] ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway
    Mao, Weipu
    Wang, Keyi
    Sun, Si
    Wu, Jianping
    Chen, Ming
    Geng, Jiang
    Luo, Ming
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [26] Effect of nicastrin on hepatocellular carcinoma proliferation and apoptosis through PI3K/AKT signalling pathway modulation
    Wang, Xicheng
    Wang, Xining
    Xu, Yunxiuxiu
    Yan, Maolin
    Li, Wenxin
    Chen, Jie
    Chen, Tao
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [27] KRT80 in hepatocellular carcinoma plays oncogenic role via epithelial-mesenchymal transition and PI3K/AKT pathway
    Hua, Ruheng
    Yan, Xiyue
    He, Jun
    Wu, Nuwa
    Yu, Wangjianfei
    Yu, Pengfei
    Qin, Lei
    IUBMB LIFE, 2025, 77 (01)
  • [28] Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
    Zhou, Qian
    Lui, Vivian W. Y.
    Yeo, Winnie
    FUTURE ONCOLOGY, 2011, 7 (10) : 1149 - 1167
  • [29] Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway
    Zheng, Ying
    Wang, Xuemei
    Wang, Haidong
    Yan, Wei
    Zhang, Quan
    Chang, Xin
    TUMOR BIOLOGY, 2014, 35 (06) : 5189 - 5198
  • [30] Interleukin-22 promotes the proliferation and migration of hepatocellular carcinoma cells via the phosphoinositide 3-kinase (PI3K/AKT) signaling pathway
    Mansur, Fizzah
    Arshad, Tanzeela
    Liska, Vaclav
    Manzoor, Sobia
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (07) : 5957 - 5967